The $69 billion CVS-Aetna merger has been approved by the Justice Department with conditions. Aetna had to agree to sell its private Medicare drug plans for the deal to be OK’d. The companies say they can “improve the consumer healthcare experience,” according a statement from CVS Health CEO Larry Merlo. (New York Times)

The 2018 MM&M Awards, celebrating outstanding work in healthcare marketing, will take place tonight in New York City. If you aren’t attending the event, follow the hashtag #MMMAwards on Twitter for updates — and stay tuned for an email alert on the award winners. (MM&M)

Democrats are concerned about how the Food and Drug Administration plans to regulate digital health apps and other software, writing a letter to the government agency asking for changes to the framework. The concerns stem from the FDA working with companies such as Apple and Fitbit to develop a program allowing companies to sell medical software without an agency review. (STAT)

Doctors should have more access to patients’ personal data, according to Facebook head of health research Dr. Freddy Abnousi. He contended that social and behavioral characteristics outweigh other key factors affecting mortality rates, such as genetics, exposure to risks, and access to healthcare. Abnousi did not say the data should come from Facebook or Instagram. (CNBC)

CRISPR Therapeutics and Vertex have received the OK from the FDA to test their sickle cell treatment. This comes after the program was put on clinical hold five months ago. The companies did not say how they resolved the FDA’s concerns. (Endpoints)